01 - The Fund targets a 12% annual preferred return for Limited Partners, calculated on invested capital and paid prior to General Partner participation, subject to fund performance.
02 - Distributions are expected to be generated from operating cash flow of the pediatric clinic platform MSO, including clinical revenue and managed service income, and are anticipated to be made on a quarterly basis, subject to performance, capital needs, and liquidity considerations.
03 - Limited Partners receive their pro rata share of distributions until the preferred return is satisfied. Thereafter, remaining profits are distributed pursuant to the Fund’s waterfall structure, aligning General Partner participation with long-term performance and enterprise value growth.